Delivery Order SPE2DR25D3013-SPE2DR26F7A1S
Award Date 2/24/26
Potential Completion Date 2/25/26
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,607.32 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for Zepbound 5 mg/0.5 mL pen (tirzepatide injection). The order is placed under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for Zepbound 15 mg/0.5 mL pen (tirzepatide injection), with a ceiling value of $3,214.64. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 6, 2026. This delivery order was issued under the parent IDC held by Cencora, Inc. (parent of AmerisourceBergen Drug Corp) with DLA Troop Support Medical, a $999,999,999...
- <p>The Defense Logistics Agency issued a $2,975.20 delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for Zepbound 5 mg/0.5 mL pen (tirzepatide injection).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 11, 2026. Pricing is firm fixed price under a no-set-aside procurement.</p>
- <p>The Defense Logistics Agency issued a $65,231.57 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Zepbound 15 mg/0.5 mL pen (tirzepatide injection), with ultimate completion scheduled for February 25, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under a firm fixed price structure with no set-aside applied.</p>
- The Defense Logistics Agency (DLA) awarded a $13,570.85 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (tirzepatide) 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 7, 2025. The pharmaceutical product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,172.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 5 mg/0.5 mL pen injections on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $15,289.25 for Zepbound 5 mg/0.5 mL pen (tirzepatide injection).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 11, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $5,651.58 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pen injections. This firm fixed-price delivery order is scheduled for completion by January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injections. This is a firm fixed-price delivery order valued at $4,007.01, with an ultimate completion date of May 13, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (tirzepatide) 2.5 mg/0.5 ml pen injectors in 0.5 ml quantities. This firm fixed-price delivery order, valued at $9,394.59, represents a competitive award with no set-aside designation and is set for completion by August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving the federal medical...